Search Results for “diagnostic” – Page 5 – media

FDA Clears First Autonomous AI Diagnostic System Rolled out by University of Iowa Healthcare

The U.S. Food and Drug Administration approved the first autonomous artificial intelligence diagnostic system, IDx-DR and the University of Iowa Healthcare has become the first healthcare organization to implement it.
- Source: HealthcareIT News
- 943
- July 15, 2018
AI digital health New Approvals
Computerized ADHD – A Novel Diagnostic Tool

A new clinical trial executed under lead investigator, Professor Chris Hollis from the University of Nottingham in the UK, revealed that by adding a computerized test of attention and activity (QbTest) to standard subjective assessments, the clinicians could easily make a diagnostic decision on ADHD, with proper accuracy.
- Source: Ddu
- 544
- May 23, 2018
ADHD Researches
FDA to expedite review of IDx-DR, a breakthrough AI diagnostic system

IDx, a privately held AI diagnostics company, announced today that it has filed its De Novo submission to the FDA for IDx-DR, an AI-based system for the autonomous detection of diabetic retinopathy — a leading cause of blindness. The FDA has granted IDx-DR with a “Breakthrough Device” designation, which means the submission will receive expedited review.
- Source: prweb
- 666
- April 26, 2018
blindness diabetic retinopathy FDA IDx-DR New Approvals
Illumina and Loxo Oncology to Partner on Developing Next-Generation Sequencing-Based Pan-Cancer Companion Diagnostics

Illumina, Inc. (Nasdaq: ILMN) and Loxo Oncology (Nasdaq: LOXO) today announced a global strategic partnership to develop and commercialize a multi-gene panel for broad tumor profiling, resulting in a distributable, next-generation sequencing (NGS) based companion diagnostic (CDx) with a pan-cancer indication.
- Source: Illumina
- 501
- April 12, 2018
larotrectinib Market Views
Diagnostic Products of the Future

Panelists at the recent J.P. Morgan Healthcare Conference in San Francisco, CA were charged with separating the hype from the reality in the field of diagnostics and offered insight into what products will win in the space.
- Source: MDDI Online
- 775
- January 23, 2018
diagnostics healthcare technologies and innovations medical device Researches
TAI Diagnostics Closes $10M Financing and Establishes Collaboration Agreement with United Therapeutics

TAI Diagnostics, Inc., focused on developing innovative diagnostic tests for monitoring the health of transplanted organs, announced the final closing of a $10 million Series A preferred equity financing. The company has now raised over $21 million since its inception. The proceeds of this financing will support on-going research and development of TAI’s innovative cell-free DNA (cfDNA) transplant monitoring technology, clinical studies, and the upcoming commercial launch of its post-transplant monitoring assays performed by its CLIA and CAP accredited reference laboratory.
- Source: drugdu
- 469
- January 18, 2018
health Series TAI’s innovative cell-free DNA
Pfizer, Foundation Medicine to develop companion diagnostics for oncology treatments

Pfizer has collaborated with Foundation Medicine for the development of companion diagnostics (CDx) for its oncology portfolio.
- Source: invitrodiagnostics.medicaldevices-business-review
- 629
- January 18, 2018
Company Insight oncology Pfizer
Alveo Closes $38 Million in Series A Financing to Create Accessible Diagnostics Devices

Alveo Technologies, Inc., ("Alveo" or "the Company") whose mission it is to create affordable and accessible infectious disease diagnostic devices, announced the closing of a $38 million Series A financing raised by Maxim Merchant Capital, a division of Maxim Group LLC. The round was oversubscribed and included existing and new investors. The offering proceeds will be used to advance the optimization and commercialization of Alveo's rapid diagnostic platform for infectious diseases.
- Source: Prnewswire
- 401
- January 15, 2018
infectious diseases Market Views Series
Illumina and KingMed to develop oncology diagnostics in China

US-based gene sequencing firm Illumina has signed an agreement with Guangzhou KingMed Diagnostics Group to co-develop new oncology and hereditary disease testing applications in China.
- Source: Verdict Medical Devices
- 640
- January 9, 2018
cancer CFDA Company Insight digital health
In vitro diagnostics market value to reach $ 69 billion in 2024, says Global Data

The overall market value of in vitro diagnostics (IVD) stands at $52 billion this year, and is projected to grow at a compound annual growth rate (CAGR) of 4.2% to $69 billion in 2024. According to GlobalData, a leading data and analytics company.
- Source: news.mit
- 444
- December 12, 2017
CAGR healthcare IVD Market Views

your submission has already been received.

OK

Subscribe

Please enter a valid Email address！

Submit

The most relevant industry news & insight will be sent to you every two weeks.

more

more

Customer Services
Contact Us
Help Center

Buy on Drugdu.com
Browse Product Categories

Free APP

Follow Us

Terms & Conditions | Privacy Policy

粤ICP备16008861号

Copyright © 2016-2018 Drugdu.com. All Rights Reserved.